Unifirst Corp: Form 10-Q for the period ended May 27, 2023
Filed with the SEC on Jul 6, 2023 and accepted by EDGAR at Jul 6, 2023, 14:40 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-05-27. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-02-26 to 2023-05-27 | $576.7m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-08-28 to 2023-05-27 | $1.66bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-02-26 to 2023-05-27 | $379.4m | us-gaap:CostOfRevenue |
| Cost of revenue | 9 months2022-08-28 to 2023-05-27 | $1.10bn | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2023-02-26 to 2023-05-27 | $132.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2022-08-28 to 2023-05-27 | $372.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-02-26 to 2023-05-27 | $33.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-08-28 to 2023-05-27 | $97.5m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-02-26 to 2023-05-27 | $9.1m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-08-28 to 2023-05-27 | $26.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-02-26 to 2023-05-27 | $24.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-08-28 to 2023-05-27 | $76.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-02-26 to 2023-05-27 | $1.29 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-08-28 to 2023-05-27 | $4.06 | us-gaap:EarningsPerShareDiluted |
| Diluted shares (weighted) | 3 months2023-02-26 to 2023-05-27 | 18,748,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-08-28 to 2023-05-27 | 18,751,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-08-28 to 2023-05-27 | $142.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-08-28 to 2023-05-27 | $124.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2022-08-28 to 2023-05-27 | $16.5m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2022-08-28 to 2023-05-27 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2023-05-27 | $59.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-05-27 | $813.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-05-27 | $2.53bn | us-gaap:Assets |
| Current liabilities | At period end2023-05-27 | $258.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-05-27 | $548.7m | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-05-27 | $1.98bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-23-031977. Last ingested by Listed: Nov 3, 2026, 21:35 ET. Listed shows no prices and gives no investment advice.